Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.6849
-0.0751 (-9.88%)
At close: Jul 13, 2026, 4:00 PM EDT
0.6936
+0.0087 (1.27%)
After-hours: Jul 13, 2026, 7:36 PM EDT
Traws Pharma Employees
As of December 31, 2025, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$390,429
Profits / Employee
-$1,987,143
Market Cap
10.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 4 | 3 |
| Dec 31, 2024 | 7 | -11 | -61.11% | 6 | 1 |
| Dec 31, 2023 | 18 | 1 | 5.88% | 17 | 1 |
| Dec 31, 2022 | 17 | 2 | 13.33% | 16 | 1 |
| Dec 31, 2021 | 15 | 3 | 25.00% | 14 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Vistagen Therapeutics | 41 |
| OSR Health | 22 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| Kiora Pharmaceuticals | 13 |
| Psyence Biomedical | 12 |
| AEON Biopharma | 8 |
TRAW News
- 5 days ago - Traws Pharma Transcript: AGM 2026 - Transcripts
- 12 days ago - Traws Pharma files $139.19M mixed securities shelf - TheFly
- 12 days ago - Traws Pharma Registration statement: Registration filing - Filings
- 21 days ago - Traws Pharma provides update on tivoxavir marboxil program - TheFly
- 21 days ago - Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program - GlobeNewsWire
- 25 days ago - Traws Pharma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 weeks ago - Traws Pharma downgraded to Neutral from Buy at Ladenburg - TheFly
- 4 weeks ago - Traws Pharma influenza challenge study deferred following MHRA review - TheFly